Regeneron Pharmaceuticals
REGN
#231
Rank
NZ$138.93 B
Marketcap
$1,264
Share price
-0.87%
Change (1 day)
-4.21%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $60.54

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $64.00. In 2022 the company made an earnings per share (EPS) of $69.41 a decrease over its 2021 EPS that were of $130.97.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$60.54-12.78%
2022$69.41-47%
2021$130.97133.36%
2020$56.1269.13%
2019$33.18-14.44%
2018$38.78100.71%
2017$19.3231.78%
2016$14.6638.96%
2015$10.5572.55%
2014$6.12-17.55%
2013$7.42-44.98%
2012$13.48-422.54%
2011-$4.1892.13%
2010-$2.1849.41%
2009-$1.46-15.84%
2008-$1.73-36.88%
2007-$2.74-9.6%
2006-$3.034.12%
2005-$2.91-323.68%
2004$1.30-135.51%
2003-$3.67-24.38%
2002-$4.8556.35%
2001-$3.10187.3%
2000-$1.08-16%
1999-$1.28177.78%
1998-$0.46-35.71%
1997-$0.72-68.42%
1996-$2.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.24-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.04-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.62-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.13-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.41-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.45-91.49%๐Ÿ‡ซ๐Ÿ‡ท France